Astellas collaborates with Vir to develop its experimental prostate cancer drug
India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US
Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer